New Dako Omnis RTU antibodies

Introduction of 16 new high quality FLEX RTU antibodies for Dako Omnis.

See list of antibodies

New Dako Omnis RTU antibodies

Results you can trust

The first and only FDA-approved and
CE-IVD marked PD-L1 test for use in
non-squamous NSCLC for OPDIVO® (nivolumab).

PD-L1 IHC 28-8 pharmDx

PD-L1 IHC 28-8 pharmDx
PD-L1 IHC 28-8 pharmDx

Review of Breast Cancer Diagnosis

In collaboration with leading experts, Agilent publishes a new comprehensive review on breast cancer diagnostic testing.

Click here to download a copy

Breast Cancer White Paper
Breast cancer diagnostic review

FISH on Dako Omnis

Learn more

FISH on Dako Omnis
FISH for Dako Omnis

Breast Cancer Review

New comprehensive review on breast cancer diagnostic testing.

Download Copy

New Product Catalog Available

The 2016 Pathology Product Catalog is now available.

Download or order a copy

Events and Congresses

Meet us at congresses and events around the world.

List of future events

Country selection

Your Dako Account indicates that you are based in , you will be transfered to the web site for

Basket emptied

Your basket was emptied because of the country change.

Country selection

United States of America appears to be your location. To view country specific information on the Dako web site, please accept or change country below.

Dako Cookie Policy
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Privacy Statement

Get in Touch with Dako in Switzerland

Contact Us Directly
+41 41 760 11 66
+41 41 760 11 77

Pathology Products, Flow Cytometry Products and Specific Proteins
Dako Schweiz GmbH

Grabenstrasse 27
Postfach 1036
CH-6341 Baar

Detailed contact information

Submit an Inquiry

How would you like us to follow up?

Your session expired

You have been logged out. Log in again to retrieve your Cart.